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Background: Assessment of tissue hypoxia at the bedside has yet to be translated into daily clinical practice 
in septic shock patients. Perfusion markers are surrogates of deeper physiological phenomena. Lactate-to-
pyruvate ratio (LPR) and the ratio between veno-arterial PCO2 difference and Ca–vO2 (ΔPCO2/Ca–vO2) 
have been proposed as markers of tissue hypoxia, but they have not been compared in the clinical scenario.  
We studied acute septic shock patients under resuscitation. We wanted to evaluate the relationship of these 
hypoxia markers with clinical and biochemical markers of hypoperfusion during septic shock resuscitation.
Methods: Secondary analysis of a randomized controlled trial. Septic shock patients were randomized to 
fluid resuscitation directed to normalization of capillary refill time (CRT) versus normalization or significant 
lowering of lactate. Multimodal assessment of perfusion was performed at 0, 2, 6 and 24 hours, and included 
macrohemodynamic and metabolic perfusion variables, CRT, regional flow and hypoxia markers. Patients 
who attained their pre-specified endpoint at 2-hours were compared to those who did not.
Results: Forty-two patients were recruited, median APACHE-II score was 23 [15–31] and 28-day mortality 
23%. LPR and ΔPCO2/Ca–vO2 ratio did not correlate during early resuscitation (0–2 h) and the whole 
study period (24-hours). ΔPCO2/Ca–vO2 ratio derangements were more prevalent than LPR ones, either 
in the whole cohort (52% vs. 23%), and in association with other perfusion abnormalities. In patients who 
reached their resuscitation endpoints, the proportion of patients with altered ΔPCO2/Ca-vO2 ratio decreased 
significantly (66% to 33%, P=0.045), while LPR did not (14% vs. 25%, P=0.34).
Conclusions: Hypoxia markers did not exhibit correlation during resuscitation in septic shock patients. 
They probably interrogate different pathophysiological processes and mechanisms of dysoxia during early 
septic shock. Future studies should better elucidate the interaction and clinical role of hypoxia markers 
during septic shock resuscitation.
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Introduction
Despite recent advances in septic shock biochemical and 
clinical understanding, mortality remains around 40% (1). 
Sepsis-induced hypoperfusion leads to tissue hypoxia, cell 
and mitochondrial dysfunction, finally leading to multiorgan 
failure (2). Timely resolution of hypoperfusion through 
the judicious administration of fluids and vasoactive drugs, 
among other therapies, may deactivate this vicious cycle and 
lead to an adequate cellular oxygen delivery and recovery of 
organ function (3).
Available markers of hypoperfusion in the clinical 
practice are mere surrogates of deeper physiological 
phenomena occurring at the tissue and cellular level. Some 
markers, like central venous oxygen saturation (SvcO2) 
or the veno-arterial PCO2 difference reflect global DO2/
VO2 and flow balances (4-6). Other parameters, like 
lactate, represent complex interactions between non-
aerobic metabolism, hyperadrenergia, and liver lactate 
clearance (7). On the other side, regional perfusion 
assessment, like sublingual microcirculation (8) or near 
infrared spectroscopy (9), can assess specific tissue-derived 
parameters, which may not reflect other territories of the 
economy. Recently, capillary refill time (CRT) has emerged 
as an interesting perfusion monitor, that has a fast kinetics 
(10,11), and correlates with other perfusion parameters 
such as hepatosplanchnic indices (12). Furthermore, its 
behavior also has correlation with severity and mortality 
(13,14). 
The possibility to assess tissue hypoxia at the bedside 
has been pursued by clinicians and investigators along 
the years (15,16), but experimental methods have yet 
to be successfully translated into clinical practice. One 
proposed alternative is the lactate/pyruvate ratio (LPR). If 
the electron transport chain of the mitochondria fails due 
to tissue hypoxia, the cell uses a non-aerobic pathway to 
synthesize ATP leading to an increase of the LPR. This 
ratio has been utilized to differentiate hypoxia-related from 
other causes of hyperlactatemia, such as increased glycolysis 
without hypoxic stress (17,18). On the other hand, 
according to the Fick equation (19), the ratio between veno-
arterial PCO2 difference and Ca–vO2 (ΔPCO2/Ca–vO2) 
represents a clinical surrogate for the respiratory quotient 
and its increase could signal anaerobic metabolism (20,21). 
To the best of our knowledge, both parameters have not 
been yet compared in the clinical scenario.
Recently, the ANDROMEDA-SHOCK trial compared 
CRT- versus lactate-guided early resuscitation during 
septic shock, demonstrating benefits in mortality, 
treatment intensity and organ dysfunction for the CRT 
arm (13,14,22,23). In a subsequent randomized controlled 
trial, we assessed both resuscitation strategies in 42 
patients, in order to assess the impact of resuscitation 
strategy on fluid administration, perfusion and deep 
hypoxia markers during the study protocol, focusing on 
LPR and ΔPCO2/Ca–vO2 (24). 
The objective of this study is to perform an assessment of 
the relationship between LPR and ΔPCO2/Ca–vO2, and the 
relationship between deep hypoxia markers with clinical markers 
of hypoperfusion during the initial resuscitation of this cohort 
of septic shock patients. We present the following article/case in 
accordance with the CONSORT reporting checklist (available 
at http://dx.doi.org/10.21037/atm-20-2048).
Methods
Patient selection and study protocol
We performed a prospective randomized controlled clinical 
trial. The design, main outcome and protocolization is 
detailed in clinicaltrials.gov (NCT03762005). Major 
outcomes have been previously reported (24). Data for this 
analysis was obtained from the final study’s database.
This study was conducted during an 18-months period 
at two intensive care units of teaching hospitals in Santiago 
de Chile (Hospital Clínico de la Pontificia Universidad 
Catolica de Chile and Hospital Barros Luco Trudeau). 
Respective IRBs and Ethics committees approved the study. 
A signed informed consent was obtained from patients or 
next of kin before study inclusion.
During the study period, patients equal or older than 18 
years old, who fulfilled the following inclusion criteria were 
considered for randomization:
(I) Septic shock, defined according to SEPSIS-3 
criteria (serum lactate >2 mmol/L, with vasopressor 
requirements after initial fluid loading of 20– 
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30 mL/kg) (3).
(II) Positive fluid responsiveness state (25,26).
Exclusion criteria considered the following: >24 hours 
of septic shock onset, anticipated surgical or dialytic 
procedure during study period, pregnancy, active bleeding, 
liver cirrhosis, do-not-resuscitate status or severe ARDS. 
Randomization was performed through a computerized 
software, with a permuted block of eight and an allocation 
of 1:1 into each study arm. Concealment was maintained 
through centralization of the randomization process. 
Patients were allocated either into CRT-targeted or 
Lactate-targeted study arms.
The study protocol lasted 6 hours, and a full set of 
measurements were performed until hour 24 (see more 
detailed information in supplementary material 1). Due 
to the difference in target dynamics, CRT arm was tested 
every 30 minutes, while lactate arm every 2 hours. If the 
perfusion target was not met, additional interventions could 
be initiated at discretion by attending physicians. Other 
therapies were performed according to current guidelines of 
septic shock management (3).
Measurements and data collection
Demographic and clinical data were registered at baseline 
and throughout hospitalization until discharge. Relevant 
clinical variables, multimodal perfusion assessment, and 
deep hypoxia makers were registered at baseline (T0), 
2 hours (T2), 6 hours (T6) and 24 hours (T24).
Hemodynamic and perfusion variables (see more detailed 
information in supplementary material 1)
(I) Macrohemodynamic variables;
(II) Cardiac output (CO) and derived indices;
(III) Metabolic-related perfusion variables (11);
(IV) Capillary refill time (13);
(V) Regional flow:
(i) Sublingual microcirculation (27);
(ii) Near infrared spectroscopy (NIRS) (8,9,27);
(iii) Liver blood flow by Indocyanine green plasma 
disappearance rate (PDR-ICG) (27).
Deep hypoxia variables (see more detailed information in 
supplementary material 1)
To evaluate the presence of tissue hypoxia, we measured 
the LPR and the ΔPCO2/Ca–vO2 ratio. Pyruvate was 
determined by using pyruvate assay kit Cayman N°700470. 
ΔPCO2/Ca–vO2 ratio was calculated using a validated 
equation (20,28). In order to ease the interpretation of both 
markers, data analysis was performed with the percentage of 
abnormality of each variable, a more intuitive approach for 
clinicians. For LPR a value of 15 or more was considered 
abnormal (17). For ΔPCO2/Ca–vO2 ratio, a value of 1.4 or 
more was considered abnormal (29).
In order to assess if derangements in clinical perfusion 
markers associated with deep hypoxia markers, we assessed 
the incidence of abnormal hypoxia markers when each 
clinical parameter presented abnormal values, at any 
timepoint.
“Target reachers” analysis
Patients of both study arms who attained their prespecified 
perfusion target at T2 were considered target reachers, 
while those who did not were considered target non-
reachers. We chose this timepoint as it was the first moment 
at which new measurements were made in both arms after 
randomization. Both groups were compared according to 
baseline characteristics and perfusion state. Evolution of 
deep hypoxia variables represented as percentage of patients 
with abnormal values, were compared through time in both 
groups.
Statistical analysis
After discarding normal distribution, non-parametric 
tests were used. Descriptive statistics are shown as median 
[interquartile range] or percentage (%) accordingly. Mann-
Whitney U, chi-square and Fisher’s exact, were used when 
appropriate. Data were analyzed with Minitab v17 (Minitab 
Inc, State College, PA) and GraphPad Prism (GraphPad 
Softwares, La Joya, CA) softwares. Two-tailed P value <0.05 
was considered statistically significant.
Results
Forty-two patients were included in this analysis. 
Demographic, hemodynamic, and other parameters are 
shown in Table 1. Main septic foci were abdominal (57%), 
respiratory (19%) and urinary (12%). Among rescue 
therapies implemented, 18% used steroids, 18% used 
epinephrine, and 13% used high-volume hemofiltration.
One hundred and twenty-five measurements of LPR and 
121 measurements of ΔPCO2/Ca–vO2 ratio were available 
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Table 1 General characteristics of the included population
Parameter Value
Age (years) 63 [47–75]
Female (%) 55
APACHE-II 23 [15–31]
SOFA 10 [7–13]
Charlson index 1 [0–4]
Septic foci (%)
Abdominal 57
Respiratory 19
Urinary 12
Other 12
Surgical (%) 60
Pre ICU fluids (mL) 2,250 [1,000–3,025]
MAP (mmHg) 71 [63–76]
HR (bpm) 104 [93–130]
CVP (mmHg) 8 [5–11]
Cardiac index (L/min/m2) 2.9 [2–3.6]
Norepinephrine dose (mcg/kg/min) 0.29 [0.17–0.48]
CRT (s) 6 [3–6]
Lactate (mmol/L) 3.6 [2.9–6.4]
ScvO2 (%) 70 [62–78]
Delta pCO2(v-a) (mmHg) 8 [4.8–11]
ΔPCO2/Ca–vO2 1.9 [1.1–2.8]
LPR 8.7 [4.2–13.8]
MV days 5 [2–10]
ICU LOS (days) 8 [4–15]
Hospital LOS (days) 25 [9–56]
28-day mortality (%) 23
APACHE II, Acute Physiology and Chronic Health Evaluation 
II; SOFA, Sequential Organ Failure Assessment score; MAP, 
mean arterial pressure; DBP, diastolic blood pressure; CVP, 
central venous pressure; CRT, capillary refill time; ScvO2, central 
venous oxygen saturation Delta pCO2(v-a), difference between 
central venous carbon dioxide pressure and arterial carbon 
dioxide pressure; ΔPCO2/Ca–vO2, ratio between veno–arterial 
PCO2 difference and Ca–vO2; LPR, lactate/pyruvate ratio; MV, 
mechanical ventilation; LOS, length of stay.
during the study period. In 94 occasions both indices were 
measured simultaneously at specific time-points, and 51 
of these measurements corresponded to the first 2 hours. 
Of these, 22% of LPR and 52% of ΔPCO2/Ca–vO2 ratio 
exhibited abnormal values. Figure 1 shows the lack of 
correlation between both hypoxia markers, both at early 
resuscitation (0-2 h, panel A) and the whole study period 
(0–24 h, panel B).
Patients with abnormal LPR at baseline (6), compared to 
those with normal LPR (27) had higher CRT {7 [5–14] vs. 
4 [3–6], P=0.02}, but similar APACHE score, lactate levels, 
NE dose, and 28-day mortality. Patients with abnormal 
ΔPCO2/Ca–vO2 ratio at baseline (19), compared to those 
with normal ratio (14), presented higher baseline lactate 
levels {6.1 [3–8.4] vs. 3.4 [2.7–4.1], P=0.049}, but similar 
severity scores and mortality.
The incidence of abnormal hypoxia markers when 
different perfusion-related parameters were abnormal at 
any time point is shown in Table 2. As seen, abnormal values 
Figure 1 Concordance between LPR and ΔPCO2/Ca–vO2 at 
initial septic shock resuscitation (0–2 h) and the whole study period 
(24 h). LPR, lactate/pyruvate ratio; ΔPCO2/Ca–vO2: ratio between 
veno–arterial PCO2 difference and Ca–vO2.
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Table 2 Presence of abnormal hypoxia markers in patients with abnormal perfusion markers
Abnormal parameter Abnormal ΔPCO2/Ca–vO2 Abnormal LPR P
Lactate >2 mmol/L 69% (58/84) 15% (13/87) 0.0001
ScvO2 <70% 55% (33/60) 5% (3/56) 0.0001
CRT >3 s 64% (35/55) 22% (12/53) 0.0001
Delta pCO2(v-a) >6 mmHg 85% (41/48) 16% (7/45) 0.0001
StO2 <70% 62% (13/21) 0% (0/24) 0.0001
PDR <18% 78% (35/45) 12% (6/51) 0.0001
MFI <2.5 85% (6/7) 42% (3/7) 0.26
ΔPCO2/Ca–vO2, ratio between veno–arterial PCO2 difference and Ca–vO2; LPR, Lactate/pyruvate ratio; CRT, Capillary refill time;  ScvO2, 
central venous oxygen saturation Delta pCO2(v-a), difference between central venous carbon dioxide pressure and arterial carbon dioxide 
pressure; StO2, Tissue oxygen saturation; PDR-ICG, liver blood flow by Indocyanine green plasma disappearance rate; MFI, mean flow 
index.
of ΔPCO2/Ca–vO2 ratio were significantly more prevalent 
than LPR alterations in the context of any abnormal 
perfusion-related parameter.
In 50% of patients cardiac output increased with fluid 
loading between T0 and T2, while the others it remained 
constant or decreased. LPR and ΔPCO2/Ca–vO2 tended 
to improve in patients who increased cardiac output 
[delta LPR: 0.89 (0.15–4) vs. −0.12 (−2–2.2), P=0.12; delta 
ΔPCO2/Ca–vO2 ratio: 0.48 (0.04–1) vs. −0.01 (−0.42–0.3), 
P=0.11].
Eighteen patients were considered target reachers at 
2 hours, while 24 patients were not. Table 3 shows the main 
clinical, demographic, severity and perfusion characteristics 
of both subgroups. As shown in Figure 2, target reachers 
significantly decreased the proportion of abnormal ΔPCO2/
Ca–vO2 ratio between 0 and 2 hours, while this did not 
occur in LPR. On the other hand, target non-reachers 
maintained similar proportions of abnormal deep hypoxia 
markers.
Discussion
Our study showed that in a population of fluid responsive 
patients with septic shock according to SEPSIS-3 (septic 
patients with hyperlactatemia and vasopressors for arterial 
hypotension), the presence of concurrent abnormal values 
of deep tissue hypoxia markers is erratic during early 
resuscitation. In addition, measured hypoxia markers do 
not exhibit concordance between them. However, further 
analysis of our results suggests that both LPR and ΔPCO2/
Ca–vO2 ratio interrogate different pathways on the hypoxia/
hypoperfusion processes of septic shock.
Lactate prognostic value and response to therapy is 
well established in the literature (30,31), and is still the 
main resuscitation target recommended by the Surviving 
Sepsis Campaign for septic shock (3). Its use was primarily 
advocated under the hypothesis that decreases in tissue 
blood flow cause tissue hypoxia that increases non-aerobic 
lactate production due to low mitochondrial oxygen 
availability (30,32). This latter condition results in tissue 
injury that leads to organ failure and subsequent morbidity 
and mortality.
Nevertheless, though by shock definition each patient in 
our series had hyperlactatemia, only few of them presented 
a high LPR. We believe that the explanation for these 
findings can be drawn after reviewing previous reports on 
the topic:
Levy studied 60 patients with septic shock, lactic acidosis 
and vasopressor requirements (33). In them, higher lactate 
levels were closely related with elevated LPRs with a notable 
direct progression between severity of the septic shock 
according to norepinephrine requirements, hyperlactatemia 
levels and LPR. In the subgroup these authors called 
‘intractable septic shock’, the APACHE II score was 32 
and the norepinephrine dose 2.3 μg/kg/min. The authors 
concluded their study stating that hyperlactatemia with an 
elevated LPR is associated with the development of multiple 
organ failure and death (33). 
In the same line, Rimachi studied 17 hyperlactatemic 
septic patients, and 13 of them (75%) presented high 
LPR (17). Their APACHE II score was 21±8 and mortality 
was 58%. Norepinephrine doses were not provided, but 
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the data indicate that these patients were sicker and, 
consequently, a higher proportion of them presented an 
elevated LPR as well.
In contrast, Suistomaa studied LPR in 98 patients 
admitted to the ICU, and 32% of them presented 
hyperlactatemia (34). Although there were few septic 
patients (8/98) in this series and data on norepinephrine 
dose and mortality was not provided, it is specifically 
mentioned that hyperlactatemia was not associated with 
LPR elevation. Moreover, their APACHE II score was 
around 16, indicating that those patients were less severely 
ill. The no elevation in LPR is concordant with our data.
Considering the previously published evidence, we can 
speculate that the low prevalence of an elevated LPR may 
be explained by inclusion of less severe cases of septic shock 
in our study, which is consistent with the mortality of only 
23%. 
Regarding ΔPCO2/Ca–vO2 ratio, a retrospective 
study reported a close correlation between blood lactate 
concentration and the ΔPCO2/Ca–vO2 ratio in a cohort 
of critically ill patients (29). Monnet demonstrated that 
ΔPCO2/Ca–vO2 ratio was able to predict an increase in 
VO2 in fluid responsive septic shock patients subjected to 
volume expansion (35), a fact confirmed later by Mallat 
et al. (36).
Even though we didn’t assess VO2 systematically, 
our results are in line with these previous reports. As 
hypoperfusion resolution is the ultimate goal of VO2 
increase, we expanded the findings to a clinical scenario 
where hypoperfusion resolution was assessed at the bedside. 
Table 3 Comparison between demographic, severity scoring, and baseline perfusion variables in target reachers and non-reachers
Variable Reacher Non-reacher P
N 18 24
Age (years) 63 [47–74] 64 [43–75] 0.9
Female (%) 10 14 0.8
Surgical foci (%) 44 71 0.08
SOFA 9 [6–12] 11 [7–14] 0.19
APACHE-II 24 [15–30] 23 [15–32] 0.7
Charlson 1 [0–3] 1 [0–5] 0.5
Pre protocol fluid (mL) 2,375 [1,000–3,138] 2,025 [1,050–3,000] 0.8
Time to antibiotics (min) 60 [30–98] 60 [30–60] 0.3
CRT (seconds) 4 [3–5] 6 [3.1–8.7] 0.07
Lactate (mol/L) 3 [2.5–4.3] 4.6 [3–8.7] 0.01
Norepinephrine dose (mcg/kg/min) 0.27 [0.11–0.42] 0.3 [0.2–0.5] 0.9
ScvO2 (%) 68 [64–74] 75 [61–82] 0.3
Delta pCO2(v-a) (mmHg) 8 [6–12] 7 [3–11] 0.3
Ca–vO2 (ΔPCO2/Ca–vO2) 2.3 [1.1–2.8] 1.3 [0.9–2.5] 0.3
LPR 7.4 [4–13.8] 9.5 [5.3–14] 0.4
NIRS (%) 79 [73–83] 75 [66–82] 0.3
PDR-ICG (%) 12 [9–20] 15 [11–19] 0.6
MFI 2.4 [1.9–3] 2.5 [1–2.6] 0.6
APACHE II, Acute Physiology and Chronic Health Evaluation II; SOFA, Sequential Organ Failure Assessment score; MAP, mean arterial 
pressure; DBP, diastolic blood pressure; CVP, central venous pressure; CRT, Capillary refill time;  ScvO2, central venous oxygen saturation 
delta pCO2(v-a), difference between central venous carbon dioxide pressure and arterial carbon dioxide pressure; ΔPCO2/Ca–vO2, ratio 
between veno–arterial PCO2 difference and Ca–vO2; LPR, lactate/pyruvate ratio; NIRS, near-infrared spectophotoscopy; PDR-ICG, liver 
blood flow by Indocyanine green plasma disappearance rate  MFI, Mean flow index
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In practical terms, a ΔPCO2/Ca–vO2 ratio normalization 
could work as a surrogate for an effective rise on DO2 with 
a concurrent correction of the oxygen debt, or an effective 
flow rectification. In other words, in this scenario, fluid 
responsiveness with ΔPCO2/Ca–vO2 ratio improvement 
after fluid loading could be an indirect marker of VO2 
improvement as evidence of flow responsiveness. This 
can ultimately explain the reason why LPR and ΔPCO2/
Ca–vO2 ratio are not concordant as they interrogate 
different mechanisms and subcellular processes of the 
pathophysiology of septic shock. Of course, another 
possibility is that the lack of correlation simply is due to the 
slower kinetics of recovery of lactate as compared to the 
rapid changes in O2 and CO2 metabolism/production.
Despite the fact that LPR clinical use has been 
abandoned due to technical complexities and that ΔPCO2/
Ca–vO2 ratio has not found its place as a functional marker 
for hypoxia in septic shock, in light of our results, we think 
that these markers may have a relevant place in the clinical 
understanding and management of the septic shock patient.
Limitations
This study has several limitations. First, this is a post hoc 
analysis of a randomized controlled trial. Second, there 
were some missing values of perfusion variables, mainly 
due to problems in the preanalytical phase. Third, some 
technical issues around pyruvate measurements were 
present. However, our lab personnel have a long-time 
experience with biologic samples handling and processing. 
Finally, there is no universal acceptance on the best method 
to clinically assess the respiratory quotient (i.e., the ratio 
between VCO2 and VO2), including the use of central 
venous gases over mixed venous gases and the use of CO2 
and O2 pressures over arterial and venous content (21,37,38). 
Despite this, recent evidence has provided support for this 
practical approach (28), which is the one we used in our 
study.
Conclusions
To our knowledge, this is the first time that the LPR and 
ΔPCO2/Ca–vO2 ratios were compared as hypoxia markers. 
Despite the huge experimental and theoretical backgrounds, 
at first, we found no evident correlation between their 
kinetics. Nevertheless, exploring the contexts for these 
markers we believe that LPR may help on the assessment of 
the depth of the dysoxia state and eventually as a prognostic 
marker, and that the ΔPCO2/Ca–vO2 ratio may serve as 
a more precise signal for flow rectification in previously 
hypoperfused fluid responsive patients subjected to fluid 
resuscitation. Undoubtedly, further information on the 
best scenarios where LPR and ΔPCO2/Ca–vO2 ratios may 
exhibit their full usefulness is still to be gathered.
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Study protocol
Each s tudy  arm had  a  spec i f i c  per fus ion  target 
(normalization or 20% decrease of serum lactate levels, 
or normalization of CRT).  When there was an abnormal 
perfusion target, fluid challenges were performed (500 of 
crystalloids in 30 minutes) until normalization of target, 
negativization of fluid responsiveness or pre-defined safety 
limits were met (i.e., raise in central venous pressure of 
5 cmH2O or more).  
Hemodynamic and perfusion variables
Macrohemodynamic variables, including, mean arterial 
pressure, CV, heart rate, norepinephrine dose (NE dose); 
fluid responsiveness state; fluid boluses, fluid balance, and 
outputs.
Cardiac output (CO) and derived indices, measured 
either with a pulse-contour CO technique (PiCCO device) 
or a pulmonary artery catheter.
Metabolic-related perfusion variables, such as arterial 
lactate, central venous-arterial (pCO2) gradient [P(cv-a)
CO2] (6), and central venous oxygen saturation (ScvO2) (5).
Capillary refill time measured with a standardized 
technique (13).
Regional flow
Sublingual microcirculation
Assessed through side dark field (SDF) device. At least five 
10–20 second videos were recorded by an expert user and 
analyzed manually according to recent recommendations. 
Then, we calculated the microcirculatory flow index 
(MFI). A value ≤2.5 was considered microcirculatory 
hypoperfusion (27).
Near infrared spectroscopy (NIRS)
A NIRS probe was placed in the skin of the thenar 
eminence, in order to assess muscle oxygen saturation 
(StO2), with a tissue spectrometer (InSpectra Model 325; 
Hutchinson Tc, Mn, USA). Values of StO2 <70% was 
considered abnormal (8,9,27).
Liver blood flow
Indocyanine green plasma disappearance rate (PDR-ICG) 
was measured with a transcutaneous assessment if ICG 
clearance, measured through a finger clip and connected 
to a liver function monitor (LiMON-Pulsion Medical 
Systems, Munich, Germany) 0.25 mg/kg of ICG was 
injected through a central line. Normal ranges described for 
PDR-ICG is 18% to 25% per minute, and we considered a 
value <15%/min as categorically abnormal, thus suggesting 
liver hypoperfusion assuming stable liver function (27).
Deep hypoxia variables
Briefly, plasma from venous blood (using EDTA as an 
anticoagulant) was obtained by centrifugation of the sample 
and then deproteinate followed by centrifugation and 
posterior neutralization with potassium carbonate. The 
pyruvate level was fluorescently determined by enzymatic 
reaction coupled to resorufin production. The relationship 
was then calculated as lactate divided to pyruvate, and a 
value of 15 or more was considered abnormal (17). 
PaCO2 − PvCO2/[(SaO2 − SvO2) × Hb × 1.36]; whereas 
PaCO2 and PvCO2 are arterial and central venous carbon 
dioxide, respectively, SaO2 is arterial saturation of oxygen 
and Hb is hemoglobin. A value of 1.4 or more was 
considered abnormal (20,28,29).
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